In Balancing Competing Interests, India’s New Pharma Secretary Likens Her Role To A Trapeze Artist
This article was originally published in PharmAsia News
Executive Summary
India’s new Department of Pharmaceuticals Secretary Aradhana Johri compared her role to that of a trapeze artist to balance rival interests, like ensuring affordable medicines while safeguarding the industry. But on the issue of exports, Johri said India will strongly negotiate against the “specious issue” of quality that she says is raised in other countries to simply exclude the Indian industry.